FIRST AMENDMENT TO THE LEASE BETWEEN B. F. SAUL REAL ESTATE INVESTMENT TRUST AND BBI-BIOTECH RESEARCH LABORATORIES, INC.Lease • January 31st, 2008 • Seracare Life Sciences Inc • In vitro & in vivo diagnostic substances
THIS FIRST AMENDMENT TO LEASE is made and entered into this 14th day of OCTOBER, 1997 by and between B. F. SAUL REAL ESTATE INVESTMENT TRUST (hereinafter referred to as “Landlord”) and BBI-BIOTECH RESEARCH LABORATORIES, INC., a Massachusetts corporation (hereinafter referred to as “Tenant”),
SECOND AMENDMENT TO THE LEASE BETWEEN B. F. SAUL REAL ESTATE INVESTMENT TRUST AND BBI-BIOTECH RESEARCH LABORATORIES, INC.Lease • January 31st, 2008 • Seracare Life Sciences Inc • In vitro & in vivo diagnostic substances
THIS SECOND AMENDMENT TO LEASE is made and entered into this 9 day of December, 1997 by and between B. F. SAUL REAL ESTATE INVESTMENT TRUST (hereinafter referred to as “Landlord”) and BBI-BIOTECH RESEARCH LABORATORIES, INC., a Massachusetts corporation (hereinafter referred to as “Tenant”),
FORM OF LANDLORD’S LIEN SUBORDINATION AGREEMENTLandlord’s Lien Subordination Agreement • January 31st, 2008 • Seracare Life Sciences Inc • In vitro & in vivo diagnostic substances
This Agreement (“Agreement”) is made as of the 9 day of JULY, 2007, by and between SAUL HOLDINGS LIMITED PARTNERSHIP, a Maryland limited partnership (hereinafter called “Landlord”), and MERRILL LYNCH BUSINESS FINANCIAL SERVICES INC., a Delaware corporation (hereinafter called “Secured Party”).
OFFICE LEASE INDEXLease • January 31st, 2008 • Seracare Life Sciences Inc • In vitro & in vivo diagnostic substances
THIS LEASE, made this 16th day of May, 1997, by and between B.F. SAUL REAL ESTATE INVESTMENT TRUST (hereinafter “Landlord”); and BBI-BIOTECH RESEARCH LABORATORIES, INC., a Massachusetts corporation (hereinafter “Tenant”).
THIRD AMENDMENT TO LEASELease • January 31st, 2008 • Seracare Life Sciences Inc • In vitro & in vivo diagnostic substances
THIS THIRD AMENDMENT TO LEASE (“Third Amendment”) is made and entered into this 14 day of June, 2007 (“Amendment Date”) by and between Saul Holdings Limited Partnership as successor-in-interest to B. F. Saul Real Estate Investment Trust (hereinafter referred to as “Landlord”) and SeraCare Life Sciences, Inc., a Delaware corporation, as successor-in-interest to BBI-Biotech Research Laboratories, Inc. (hereinafter referred to as “Tenant”).
SeraCare Life Sciences, Inc.Employment Agreement • January 31st, 2008 • Seracare Life Sciences Inc • In vitro & in vivo diagnostic substances • California
This Employment Agreement (the “Agreement”) is entered into by and between SeraCare Life Sciences, Inc. (the “Company”) and Ronald R. Dilling (“Employee”), as of the 13th day of January, 2006 (the “Effective Date”).
